Blb&B Advisors, LLC Eli Lilly & CO Transaction History

Blb&B Advisors, LLC

$1.93 Billion
Q1 2025

A detailed history of Blb&B Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Blb&B Advisors, LLC holds 2,962 shares of LLY stock, worth $2.22 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,962

Previous 2,920 1.44%

Holding current value

$2.22 Million

Previous $2.25 Million 8.52%

% of portfolio

0.13%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$725.72 - $929.72 $30,480 - $39,048	42 Added 1.44%	2,962 $2.45 Million
Q4 2024 Jan 28, 2025	SELL	$727.2 - $932.06 $125,078 - $160,314	-172 Reduced 5.56%	2,920 $2.25 Million
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $11,582 - $14,400	15 Added 0.49%	3,092 $2.74 Million
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $189,915 - $238,168	262 Added 9.31%	3,077 $2.79 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $3,553 - $4,753	-6 Reduced 0.21%	2,815 $2.19 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $78,778 - $92,869	150 Added 5.62%	2,821 $1.64 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $3,912 - $5,393	-9 Reduced 0.34%	2,671 $1.43 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $132,930 - $177,743	-379 Reduced 12.39%	2,680 $1.26 Million
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $115,864 - $136,077	-373 Reduced 10.87%	3,059 $1.05 Million
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $57,879 - $67,440	180 Added 5.54%	3,432 $0
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $66,708 - $76,020	-225 Reduced 6.47%	3,252 $1.05 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $45,990 - $53,999	-165 Reduced 4.53%	3,477 $1.13 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $4,459 - $5,541	-19 Reduced 0.52%	3,642 $1.04 Million
Q4 2021 Jan 21, 2022	SELL	$224.85 - $279.04 $1.27 Million - $1.57 Million	-5,630 Reduced 60.6%	3,661 $1.01 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $1.1 Million - $1.36 Million	4,970 Added 115.02%	9,291 $2.15 Million
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $12,819 - $16,581	71 Added 1.67%	4,321 $992,000
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $1.19 Million - $1.54 Million	-7,257 Reduced 63.07%	4,250 $794,000
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $856,991 - $1.13 Million	6,569 Added 133.03%	11,507 $1.94 Million
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $7,457 - $8,625	-51 Reduced 1.02%	4,938 $731,000
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $48,974 - $58,940	-359 Reduced 6.71%	4,989 $819,000
Q1 2020 Apr 21, 2020	SELL	$119.05 - $147.35 $24,405 - $30,206	-205 Reduced 3.69%	5,348 $742,000
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $21,384 - $26,486	-200 Reduced 3.48%	5,553 $730,000
Q3 2019 Oct 22, 2019	SELL	$106.79 - $116.16 $32,570 - $35,428	-305 Reduced 5.03%	5,753 $643,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $71,348 - $83,282	-644 Reduced 9.61%	6,058 $671,000
Q1 2019 Apr 19, 2019	SELL	$111.31 - $131.02 $47,306 - $55,683	-425 Reduced 5.96%	6,702 $870,000
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $8,366 - $9,372	-79 Reduced 1.1%	7,127 $825,000
Q2 2018 Jul 11, 2018	SELL	$75.7 - $86.88 $56,245 - $64,551	-743 Reduced 9.35%	7,206 $615,000
Q1 2018 Apr 09, 2018	SELL	$74.21 - $87.6 $7,420 - $8,760	-100 Reduced 1.24%	7,949 $615,000
Q4 2017 Jan 16, 2018	SELL	$81.94 - $87.89 $20,894 - $22,411	-255 Reduced 3.07%	8,049 $680,000
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $639,989 - $710,324	8,304	8,304 $710,000

Others Institutions Holding LLY

# of Institutions

4,392

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account

Blb&B Advisors, LLC Eli Lilly & CO Transaction History